154 related articles for article (PubMed ID: 31025168)
1. ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells).
Prieto-Nieto MI; Pastor D; Rodríguez-Cobos J; Pérez JP; Méndez C; Palacios E; Arranz-Alvarez M; Santos-López J; Cano-Vega M; Viñal D; Rodríguez N; Domínguez G
Clin Transl Oncol; 2019 Oct; 21(10):1432-1439. PubMed ID: 31025168
[TBL] [Abstract][Full Text] [Related]
2. Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Zambrano-Vera K; Sardi A; Munoz-Zuluaga C; Studeman K; Nieroda C; Sittig M; King MC; Sipok A; Gushchin V
Ann Surg Oncol; 2020 Jan; 27(1):179-187. PubMed ID: 31646450
[TBL] [Abstract][Full Text] [Related]
3. Effects of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Goblet Cell Carcinoma: A Prospective Cohort Study.
Madsen AH; Ladekarl M; Villadsen GE; Grønbæk H; Sørensen MM; Stribolt K; Verwaal VJ; Iversen LH
Ann Surg Oncol; 2018 Feb; 25(2):422-430. PubMed ID: 29214450
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: an emerging treatment option for advanced goblet cell tumors of the appendix.
McConnell YJ; Mack LA; Gui X; Carr NJ; Sideris L; Temple WJ; Dubé P; Chandrakumaran K; Moran BJ; Cecil TD
Ann Surg Oncol; 2014 Jun; 21(6):1975-82. PubMed ID: 24398544
[TBL] [Abstract][Full Text] [Related]
5. Risk of Ovarian Involvement in Advanced Colorectal or Appendiceal Tumors Involving the Peritoneum.
Mehta AM; Bignell MB; Alves S; Dayal SP; Mohamed F; Cecil TD; Moran BJ
Dis Colon Rectum; 2017 Jul; 60(7):691-696. PubMed ID: 28594718
[TBL] [Abstract][Full Text] [Related]
6. Combined classical carcinoid and goblet cell carcinoid tumor: a new morphologic variant of carcinoid tumor of the appendix.
Chetty R; Klimstra DS; Henson DE; Albores-Saavedra J
Am J Surg Pathol; 2010 Aug; 34(8):1163-7. PubMed ID: 20631606
[TBL] [Abstract][Full Text] [Related]
7. Goblet Cell Carcinoid/Carcinoma: An Update.
Zhang K; Meyerson C; Kassardjian A; Westbrook LM; Zheng W; Wang HL
Adv Anat Pathol; 2019 Mar; 26(2):75-83. PubMed ID: 30601149
[TBL] [Abstract][Full Text] [Related]
8. Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids.
Radomski M; Pai RK; Shuai Y; Ramalingam L; Jones H; Holtzman MP; Ahrendt SA; Pingpank JF; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2016 Dec; 23(13):4338-4343. PubMed ID: 27401448
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis: Our Initial Experience.
Bartoş A; Bartoş D; Raluca S; Mitre C; Hadade A; Iancu I; Cioltean C; Iancu C; Militaru C; Părău A; Breazu C
Chirurgia (Bucur); 2019; 114(2):222-233. PubMed ID: 31060655
[No Abstract] [Full Text] [Related]
10. Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Mehta A; Mittal R; Chandrakumaran K; Carr N; Dayal S; Mohamed F; Moran B; Cecil T
Dis Colon Rectum; 2017 Nov; 60(11):1155-1161. PubMed ID: 28991079
[TBL] [Abstract][Full Text] [Related]
11. Appendiceal goblet cell carcinoid and mucinous neoplasms are closely associated tumors: lessons from their coexistence in primary tumors and concurrence in peritoneal dissemination.
Ng D; Falck V; McConnell YJ; Mack LA; Temple WJ; Gui X
J Surg Oncol; 2014 May; 109(6):548-55. PubMed ID: 24374723
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Surgical and Chemotherapeutic Treatments of Goblet Cell Carcinoid Tumors of the Appendix.
Tsang ES; McConnell YJ; Schaeffer DF; Lee L; Yin Y; Zerhouni S; Schaff K; Speers C; Kennecke HF
Ann Surg Oncol; 2018 Aug; 25(8):2391-2399. PubMed ID: 29916007
[TBL] [Abstract][Full Text] [Related]
13. Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed.
Modlin IM; Kidd M; Latich I; Zikusoka MN; Eick GN; Mane SM; Camp RL
Ann Surg; 2006 Jul; 244(1):52-60. PubMed ID: 16794389
[TBL] [Abstract][Full Text] [Related]
14. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
[TBL] [Abstract][Full Text] [Related]
15. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
[TBL] [Abstract][Full Text] [Related]
16. Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma.
Aziz O; Jaradat I; Chakrabarty B; Selvasekar CR; Fulford PE; Saunders MP; Renehan AG; Wilson MS; O'Dwyer ST
Dis Colon Rectum; 2018 Jul; 61(7):795-802. PubMed ID: 29771808
[TBL] [Abstract][Full Text] [Related]
17. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
18. Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection.
Enomoto LM; Choudry MH; Bartlett DL; Totin L; Mann GN; Skitzki JJ; Perry KC; Votanopoulos KI; Levine EA; Shen P
Ann Surg Oncol; 2020 Jan; 27(1):107-114. PubMed ID: 31368017
[TBL] [Abstract][Full Text] [Related]
19. Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Randle RW; Griffith KF; Fino NF; Swett KR; Stewart JH; Shen P; Levine EA; Votanopoulos KI
J Surg Res; 2015 Jun; 196(2):229-34. PubMed ID: 25881787
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC.
Graf W; Cashin PH; Ghanipour L; Enblad M; Botling J; Terman A; Birgisson H
Ann Surg Oncol; 2020 Jan; 27(1):293-300. PubMed ID: 31571052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
